D-1461-2016 Class II Terminated
FDA drug recall D-1461-2016 was initiated by Zydus Pharmaceuticals USA Inc on Jul 19, 2016 and is designated Class II. Reason for recall: Failed Dissolution Specifications: out of specification dissolution results in retained samples The recall status is terminated (terminated Sep 21, 2020).
Recall details
- Product Type
- Drugs
- Report Date
- Aug 24, 2016
- Initiation Date
- Jul 19, 2016
- Termination Date
- Sep 21, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.
Reason for recall
Failed Dissolution Specifications: out of specification dissolution results in retained samples
Distribution pattern
Nationwide
Code information
Lot #: a) MS1217, MS1218 , Exp.12/2017. Lot #: b) MS1215, Exp.12/2017 Lot #: c) MR11150, MR11151, MR11854, Exp. 10/2017; MR11798, MR11799, MS1214, Exp.11/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1461-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026